Back to EP Wealth Advisors, LLC EP Wealth Advisors, LLC

SPROSPRO

2 quarters

Position history for EP Wealth Advisors, LLCEP Wealth Advisors, LLC's holdings in Spero Therapeutics, Inc.

No. EP Wealth Advisors exited its SPRO (Spero Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 16,500 shares worth $11,880. EP Wealth Advisors first reported SPRO in Q1 2025 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$11,880

Total Shares Change

-16,500

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$2.90
0
2025-Q1
New
16,500
—
$11,8800.0%$0.72
24

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used